SEC Form D private-offering filing
Stipple Bio, Inc.
A new SEC Form D private-offering notice from Cambridge, MA, a $100,200,007 filer-stated offering target in Biotech. The source filing is one click away.
Precision oncology biotech using its Pointillist epitope discovery platform to identify tumor specific cell surface targets for antibody drug conjugates; recently closed a $100 million Series A.
Filed 2026-04-06Filed to raise $100,200,007First money in 2026-03-31Raised so far $65,130,013HQ (as filed) Cambridge, MASector Biotech ✓Stage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified stipple.bio↗Named in the filing 7 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.